Популярное

Музыка Кино и Анимация Автомобили Животные Спорт Путешествия Игры Юмор

Интересные видео

2025 Сериалы Трейлеры Новости Как сделать Видеоуроки Diy своими руками

Топ запросов

смотреть а4 schoolboy runaway турецкий сериал смотреть мультфильмы эдисон
dTub
Скачать

A Company's New Longevity Senolytic Drug & The Drug Development Process | 54 - David Scieszka

Автор: Dr Matt Kaeberlein

Загружено: 2024-08-01

Просмотров: 4478

Описание:

Subscribe to our channel:    / @optispan  

Check out Vertical Longevity Pharma: https://vertical-longevity-pharma.com/

Matt recently attended the 52nd annual meeting of the American Aging Association (AGE) in Madison, Wisconsin and met with several people doing fascinating work in or adjacent to the geroscience field.

His last guest from the AGE meeting is David Scieszka, a longevity entrepreneur with a unique background that includes work as a PsyOps specialist for the US Army. David is currently working on Vertical Longevity Pharma, a senolytics company that he spun out from his postdoctoral work. He previously lead multiomics efforts at the biotech startup Norvoc Biosciences. David holds a PhD in biomedical sciences from the University of New Mexico School of Medicine, which he did concurrently with an MBA at the UNM School of Management.

In this episode, Dave and Matt give us a peek into the drug development process (TL;DR: it isn't straightforward or cheap), from facing investor skepticism to considering endpoints, dosage, and potential side effects to collecting rigorous preclinical data that will satisfy requirements for U.S. Food and Drug Administration (FDA) approval. They also chat about further opportunities for the drug's use in companion animals, a demographic that would also enable a potentially faster path to FDA approval.

0:00 Introduction
1:00 How David became interested in geroscience and longevity
3:37 About the paper that inspired David's company
6:17 How David's company is moving forward
7:38 Why aren't more people using the GMP for the senolytic David's company is developing?
8:04 Dealing with investor skepticism
9:20 Would the senolytic cause hair regrowth?
9:50 Which endpoints is David considering as targets?
12:10 Could the drug work as a topical therapeutic?
12:27 Assuming FDA approval, what might dosage look like?
13:12 Getting around the reality that the aged immune system doesn't respond well to vaccines
14:06 Which side effects might David worry about?
16:10 Potential opportunity in companion animals
17:24 Wrapping up

Producers: Tara Mei, Nicholas Arapis
Video Editor: Jacob Keliikoa

DISCLAIMER: The information provided on the Optispan podcast is intended solely for general educational purposes and is not meant to be, nor should it be construed as, personalized medical advice. No doctor-patient relationship is established by your use of this channel. The information and materials presented are for informational purposes only and are not a substitute for professional medical advice, diagnosis, or treatment. We strongly advise that you consult with a licensed healthcare professional for all matters concerning your health, especially before undertaking any changes based on content provided by this channel. The hosts and guests on this channel are not liable for any direct, indirect, or other damages or adverse effects that may arise from the application of the information discussed. Medical knowledge is constantly evolving; therefore, the information provided should be verified against current medical standards and practices.

More places to find us:

Twitter:   / optispanpodcast  
Twitter:   / optispan  
Twitter:   / mkaeberlein  
Linkedin:   / optispan  

https://www.optispan.life/

Hi, I'm Matt Kaeberlein. I spent the first few decades of my career doing scientific research into the biology of aging, trying to understand the finer details of how humans age in order to facilitate translational interventions that promote healthspan and improve quality of life. Now I want to take some of that knowledge out of the lab and into the hands of people who can really use it.

On this podcast I talk about all things aging and healthspan, from supplements and nutrition to the latest discoveries in longevity research. My goal is to lift the veil on the geroscience and longevity world and help you apply what we know to your own personal health trajectory. I care about quality science and will always be honest about what I don't know. I hope you'll find these episodes helpful!

A Company's New Longevity Senolytic Drug & The Drug Development Process | 54 - David Scieszka

Поделиться в:

Доступные форматы для скачивания:

Скачать видео mp4

  • Информация по загрузке:

Скачать аудио mp3

Похожие видео

Everything I do for Healthspan (and why I skip THESE Supplements)

Everything I do for Healthspan (and why I skip THESE Supplements)

Владимир Пастухов* и Алексей Венедиктов*. Новогодние Пастуховские четверги! / 01.01.26

Владимир Пастухов* и Алексей Венедиктов*. Новогодние Пастуховские четверги! / 01.01.26

ДЕНЬ 1408: ВОЙНА ПРОДОЛЖИТСЯ ВЕСЬ ГОД @Kurbanova_LIVE

ДЕНЬ 1408: ВОЙНА ПРОДОЛЖИТСЯ ВЕСЬ ГОД @Kurbanova_LIVE

My Supplement Recommendations as a Longevity Scientist | EP 17 CLIP

My Supplement Recommendations as a Longevity Scientist | EP 17 CLIP

What are epigenetic clocks and do they work? | Peter Attia, M.D. & Matt Kaeberlein, Ph.D.

What are epigenetic clocks and do they work? | Peter Attia, M.D. & Matt Kaeberlein, Ph.D.

Уролитин А для здоровья митохондрий, аутофагии и многого другого: стоит ли оно того? [Исследовани...

Уролитин А для здоровья митохондрий, аутофагии и многого другого: стоит ли оно того? [Исследовани...

Дозы и время применения кверцетина и фисетина в испытаниях на людях | Modern Healthspan Clips

Дозы и время применения кверцетина и фисетина в испытаниях на людях | Modern Healthspan Clips

Сколько фруктов — это слишком много? Новый научный взгляд на фрукты

Сколько фруктов — это слишком много? Новый научный взгляд на фрукты

24 исследования спустя: 4 добавки для борьбы со старением кожи, которые работают

24 исследования спустя: 4 добавки для борьбы со старением кожи, которые работают

Будущее без работы, болезней и привычного мира | Откровенный разговор с Андреем Дороничевым

Будущее без работы, болезней и привычного мира | Откровенный разговор с Андреем Дороничевым

Эти молекулы обратили старение на... ГОДЫ! [Объяснение исследования TRIIM - Исследование 216]

Эти молекулы обратили старение на... ГОДЫ! [Объяснение исследования TRIIM - Исследование 216]

Нам никогда не рассказывали этого о креатине...

Нам никогда не рассказывали этого о креатине...

TMG + NMN: Is Your Longevity Stack Hurting You?

TMG + NMN: Is Your Longevity Stack Hurting You?

This Viral

This Viral "Whorebath" Test Is Not What You Think It Is

Алекс Жаворонков — От разработки лекарств с помощью ИИ до медицины долголетия

Алекс Жаворонков — От разработки лекарств с помощью ИИ до медицины долголетия

Greg Fahy | Thymus Regeneration: What’s Next? @ Longevity Frontiers Workshop 2023

Greg Fahy | Thymus Regeneration: What’s Next? @ Longevity Frontiers Workshop 2023

Leveraging the power of senolytics to eliminate senescence cells

Leveraging the power of senolytics to eliminate senescence cells

Why Zuck is so good at making terrible products

Why Zuck is so good at making terrible products

Device that reverses Alzheimer's cognitive decline may also increase human longevity

Device that reverses Alzheimer's cognitive decline may also increase human longevity

Most Longevity Experts Don't Tell You This About Aging | 56 - Longevity Science #8

Most Longevity Experts Don't Tell You This About Aging | 56 - Longevity Science #8

© 2025 dtub. Все права защищены.



  • Контакты
  • О нас
  • Политика конфиденциальности



Контакты для правообладателей: [email protected]